PPAR Research / 2009 / Article / Fig 1

Review Article

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?

Figure 1

Hazard ratio of chronic heart failure (CHF), acute myocardial infarction (AMI) and all cause mortality for use of TZDs versus other oral hypoglycemic drugs (95% CI). This figure shows the association of TZDs with CHF, AMI and mortality, compared with other oral hypoglycemic agents; ; [19].

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.